News

Dr. Despina Siolas was recently featured in Women’s Health discussing “12 Cancer Symptoms to Never Ignore.” As a physician–scientist, she believes it is important to step outside the lab and clinic to communicate health information that matters to the public. Subtle symptoms—such as persistent bloating, changes in bowel habits, or unexpected weight changes—can be early signs of serious underlying conditions....
Dr. Despina Siolas was selected to join the inaugural Project Purple Scientific Research Committee, a group of physician–scientists united by the shared goal of accelerating progress in pancreatic cancer research. Project Purple has long been a leader in supporting patients and funding innovative projects. Through this new committee, she will work to ensure that research investments have the greatest possible impact on advancing patient...
Our lab is excited to announce a new collaboration with Tezcat Biosciences, supported by a Phase II SBIR award from the National Cancer Institute. Together, we will conduct advanced preclinical testing of TZT-102 in KRAS-mutant pancreatic cancer, leveraging patient-derived xenograft (PDX) models to explore new therapeutic opportunities. This partnership bridges biotech innovation with academic translational research, with the shared goal...
Over the past few weeks, Dr. Despina Siolas had the privilege of presenting her research on KRAS mutant pancreatic cancer at the Cold Spring Harbor Laboratory Biology of Cancer: Metastasis and the Microenvironment meeting and at the Pancreatic Cancer Action Network Scientific Summit. From in-depth discussions of tumor biology at CSHL to collaborative efforts through the SPARK platform, these meetings reinforced a core truth—progress in...
We are proud to share that Mayar Abdelalim, an undergraduate researcher in our lab at Weill Cornell Medicine, presented her work at the 2025 AMWA Region 2 Pre-Medical Research Conference. Her project explores how tumor genetics influence immune visibility, a key question in understanding immune evasion in pancreatic cancer. Mayar’s project earned second place in recognition of...

Members of the Siolas Lab were grateful to join the Blackburn Family Cancer Foundation at UBS Arena, where the Foundation was recognized as the beneficiary of the New York Islanders’ 50/50 raffle. The Blackburn family has been a longstanding supporter of pancreatic cancer research and patient care, and their generosity plays a meaningful role in advancing the...

Dr. Despina Siolas was recently featured in GI Oncology Now to discuss the vital role of mentorship, resilience, and collaboration in translational cancer research. She emphasized the importance of guiding young scientists, cultivating perseverance, and fostering an environment where ideas and encouragement are freely exchanged. 

Read...

Our team has published new real-world evidence study addressing a rare, but clinically challenging scenario: microsatellite instability–high (MSI-H) colon cancer presenting with isolated peritoneal metastases (iPM) (Metzger et al., Cancers, 2025)....

We are excited to share that Dr. Despina Siolas has been awarded a 2025 Pilot Grant from the Parker Institute for Cancer Immunotherapy (PICI) and the Weill Cornell Medicine Meyer Cancer Center. This competitive funding supports her innovative project titled “Gut microbiota control of immune suppression in colorectal cancer liver metastases” and features collaborations with Dr. Manish Shah and Dr. Greg Sonnenberg. This work aims to explore how microbial...

Blackburns and Dr Siolas at hockey game
Pancreatic cancer is one of the deadliest forms of...

Weill Cornell Medicine Siolas Lab C-Building Room 601 New York, NY 10021 Phone: (646) 962-6200 Fax: (646) 962-1607